Literature DB >> 11352872

NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study.

S Rollinson1, P Roddam, E Willett, E Roman, R Cartwright, A Jack, G J Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11352872

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  3 in total

1.  CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.

Authors:  Vanessa S Silveira; Renata Canalle; Carlos Alberto Scrideli; Rosane G P Queiroz; Luiz Fernando Lopes; Luiz Gonzaga Tone
Journal:  Mol Cell Biochem       Date:  2012-01-04       Impact factor: 3.396

2.  N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Authors:  Azza M Kamel; Gamal T A Ebid; Heba S Moussa
Journal:  Tumour Biol       Date:  2015-03-25

3.  Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis.

Authors:  Xiaoxiao Zhu; Yanbing Liu; Guangwu Chen; Qiang Guo; Zhen Zhang; Lin Zhao; Ran Wei; Xunqiang Yin; Yunhong Zhang; Bin Wang; Xia Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.